3,3',3'',3'''-(Porphyrin-5,10,15,20-tetrayl)tetraphenol, 95%, 250mg

2,4-Quinolinedicarboxamide, N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-, 98%, 2mg

4-Dimethylaminobenzaldehyde>98.0%(GC)(T)25g

SPIRO[3.5]NONAN-1-ONE, 95.0%, 250mg

4-Bromo-2-methoxy-3-methylpyridine, 95.0%, 5g

Tapa HPLC GL 45 Conexiones sin llaves de paso, 2, 1,6 mm, 1 pieza

1,1,3,3-tetraethoxypropane, 95.0%, 100g

2,3-butadien-1-amine hydrochloride, 95.0%, 1g

2,3-Dichlorophenylacetic acid, 98.0%, 100g

N-METHYLQUINOLIN-2-AMINE, 95.0%, 1g

(2H-pyrazolo[4,3-b]pyridin-6-yl)methanamine oxalate, 95%, 1g

4-Amino-6-chloropyrimidin-5-ol, 95.0%, 250mg

1,1-DIMETHYL-3-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)UREA, 95%, 250mg